rectangle@2x
animation large icon1animation large icon2animation large icon3animation large icon4animation small icon1animation small icon2animation small icon3animation small icon4

News, Events & Insights

GET THE LATEST

Sign Up for our thought leadership, case studies,
webinars, whitepapers, and more!

 

News

Golden Gate Capital Invests in Ensemble Health Partners


colleagues

Ensemble Health Partners ("Ensemble" or "the Company"), an industry-leading national revenue cycle management provider, announced today that Bon Secours Mercy Health will sell 51 percent of the equity in Ensemble to Golden Gate Capital, a leading private equity investment firm. Bon Secours Mercy Health will continue as a commercial partner to Ensemble, as well as remain a minority owner in the Company and continue to serve on the Company's board.

Founded in 2014, Ensemble partners with hospitals across the United States to create real and lasting value through revenue cycle outsourcing and other services aimed at improving healthcare operations. The Ensemble leadership team is differentiated by its extensive experience as hospital and physician practice operators, as well as its hands-on, client-first mindset. Addressing the shift to value-based care and the changing regulatory landscape, Ensemble's proven collaborative partnership approach uses operational and process best practices, analytics and technology to craft comprehensive solutions for its clients.

With the exponential growth Ensemble has achieved, Golden Gate Capital's investment will ensure continued delivery of exceptional results for current and future partners through enhancements in technology, services and people. The transaction facilitates the next phase of growth for Ensemble, which has grown to 3,600 employees serving customers in 30 states, and more than 60 full outsource partner hospitals. Ensemble's current management team and best-in-class associates, along with its culture of transparency and mission to improve the quality and affordability of healthcare, will remain central to the Company's and Golden Gate Capital's long-term growth strategy.